The Global digital therapeutics market expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021. For instance, in 2010, U.S. Congress authorized Centers for Disease Control & Prevention (CDC) to create Diabetes Prevention Recognition Program (DPRP) & recognize programs that meet evidence-based standards provided by DPRP.
- Advertising -
Access report at www.rnrmarketresearch.com/contacts…mple?rname=626299 .
Digital therapeutics market refers to health or social care interventions delivered through a smart device to support healthy behaviors and provide therapeutic effects. Digital therapies/programs are cost-effective & have potential to improve patient engagement & bring a substantial change in patients’ health.
Owing to these advantages, digital therapeutics increasingly being prescribed to help manage long-term conditions like diabetes, insomnia, & asthma.
- Advertising -
Company Profiles (Introduction, Products & Services, Strategy, & Analyst Insights, Developments)
- Proteus Digital Health, Inc.
- Omada Health, Inc.
- Welldoc, Inc.
- Livongo Health
- Noom Inc.
- Ginger.Io, Inc.
- Propeller Health
- 2morrow Inc.
- Canary Health Inc.
- Mango Health Inc.
In digital therapeutics market Government initiatives to support development & adoption of digital therapeutics solutions also provide an impetus for growth of market. For instance, U.S. Congress authorized Centers for Disease Control and Prevention (CDC) to create Diabetes Prevention Recognition Program (DPRP) & recognize programs that meet evidence-based standards provided by DPRP.
Access report at www.rnrmarketresearch.com/contacts…ying?rname=626299 .
The global digital therapeutics market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America will continue to lead the global market in the forecast period.
Over the next five years, the growth of the market is likely to be centered on the U.S.
2 Competitive Situations and Trends
3 Partnerships, Collaborations, and Agreements
5 Other Strategies
North America dominates digital therapeutics market, with U.S. accounting for major share & highest CAGR.
This can be attributed to growing incidence of chronic diseases, government initiatives to support technological advancements in digital therapeutics, gradually improving reimbursement structure for digital therapeutics solutions, & a growing influx of new startup companies in market as a result of increasing investments in digital therapeutics field.
Access report @ www.rnrmarketresearch.com/contacts…ount?rname=626299 .
Digital therapeutics market is segmented into preventive and treatment/care-based applications. On basis of sales channel, digital therapeutics market is segmented into B2C and B2B sales channel.
B2B segment is estimated to command largest share in 2016 and register highest CAGR in digital therapeutics market, by sales channel.
Global digital therapeutics market segmented into North America, Europe, Asia-Pacific, & Rest of the World (RoW). North America expected to account for largest share of market by end of 2016.
This large share can be attributed to various factors, including growing incidence of chronic diseases, government initiatives to support technological advancements in field of digital therapeutics, & a growing influx of new startup companies in market.
Category: Market Research Publishers and RetailersCompany about: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: